The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Scaling up e-Connect in Juvenile Probation Settings

Not Applicable

Active, not recruiting

Conditions: Suicide

Interventions: Behavioral: e-Connect

First Posted Date: 2022-09-15

Last Posted Date: 2024-08-27

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 3629

Registration Number: NCT05541926

Locations: 🇺🇸
Columbia University and New York State Psychiatric Instititute, New York, New York, United States

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Not Applicable

Not yet recruiting

Conditions: Family Relations
Inflammation
CBCL
HPA

Interventions: Other: Supplemental cash transfer

First Posted Date: 2022-07-28

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 450

Registration Number: NCT05477901

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇧🇷
UNIFESP, São Paulo, SP, Brazil

Boricua Youth Study COVID-19 Coping Intervention Study

Not Applicable

Suspended

Conditions: Anxiety
Depression
Psychological Stress

Interventions: Behavioral: Mindfulness-based Intervention (Headspace TM)

First Posted Date: 2022-07-06

Last Posted Date: 2025-03-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 40

Registration Number: NCT05444881

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

Phase 3

Withdrawn

Conditions: Suicidal Ideation
Major Depressive Disorder

Interventions: Drug: Belbuca Buccal Product
Other: Placebo

First Posted Date: 2022-06-22

Last Posted Date: 2023-11-14

Lead Sponsor: New York State Psychiatric Institute

Registration Number: NCT05427981

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Shared Decision Making for Antipsychotic Medications

Not Applicable

Not yet recruiting

Conditions: Schizophrenia
Delusional Disorder
Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
Schizoaffective Disorder
Schizophreniform Disorders

Interventions: Other: The Antipsychotic Medication Decision Aid (APM-DA)

First Posted Date: 2022-06-13

Last Posted Date: 2025-03-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 120

Registration Number: NCT05416658

Scaffolding of Brain Operations

Not Applicable

Suspended

Conditions: Behavioral Performance

Interventions: Other: discrimination task

First Posted Date: 2022-06-09

Last Posted Date: 2025-05-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 170

Registration Number: NCT05412901

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Glutamatergic Mechanisms: Aim2

Phase 1

Suspended

Conditions: Healthy

Interventions: Drug: Ketamine
Drug: Ts-134
Drug: Placebo

First Posted Date: 2022-06-02

Last Posted Date: 2024-08-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 120

Registration Number: NCT05401227

Locations: 🇺🇸
NYSPI, New York, New York, United States

Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users

Not Applicable

Suspended

Conditions: Cannabis

Interventions: Device: iTBS

First Posted Date: 2022-06-02

Last Posted Date: 2023-08-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 40

Registration Number: NCT05401929

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Air Pollution and Development in the Boricua Youth Study

Not Applicable

Conditions: Pollution; Exposure
Neurodevelopmental Disorders

Interventions: Other: MRI task

First Posted Date: 2022-05-10

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 182

Registration Number: NCT05368493

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Phase 2

Not yet recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Buprenorphine SL
Other: Telehealth
Other: In-person treatment as usual

First Posted Date: 2022-04-21

Last Posted Date: 2025-04-02

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 50

Registration Number: NCT05339256

Home Terms & Conditions Privacy Policy